The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Adrenalin (epinephrine in sodium chloride)
Epinephrine in Sodium Chloride · EPINEPHRINE 8 ug/mL · Injection · Intravenous · Par Health USA, LLC
NDC 42023-0273-10 · 10 BAG in 1 CARTON / 250 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$200.00
Reported to Texas DSHS · 2026 annual filing · Par Health USA, LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 0.1 MG
$0.605
HCPCS J0163 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA215875
- TE code
- —
- Approval date
- Apr 21, 2023
- Patents / exclusivity
- 20 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11083698 | Mar 21, 2039 |
| patent | 11083698 | Mar 21, 2039 |
| patent | 11083698 | Mar 21, 2039 |
| patent | 11083698 | Mar 21, 2039 |
| patent | 11083698 | Mar 21, 2039 |
| patent | 10653646 | Mar 21, 2039 |
| patent | 11207280 | Mar 21, 2039 |
| patent | 10653646 | Mar 21, 2039 |
| patent | 12133837 | Mar 21, 2039 |
| patent | 11207280 | Mar 21, 2039 |
| patent | 11207280 | Mar 21, 2039 |
| patent | 10653646 | Mar 21, 2039 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Epinephrine in Sodium Chloride (Injection)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Par Health USA, LLC | EPINEPHRINE 16 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | EPINEPHRINE 20 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | EPINEPHRINE 32 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | EPINEPHRINE 40 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
| Par Health USA, LLC | EPINEPHRINE 8 ug/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Adrenalin (epinephrine in sodium chloride) — NDC 42023-0273-10," retrieved September 3, 2026, https://drugdashboards.com/drug/42023027310.
Free to cite with attribution — see how the data is put together.